摘要
AIM: To investigate whether adding ecabet sodium to the standard triple therapy for H pylori infection improve eradication rate. METHODS: Two hundred and fifty-seven H pylori-infected patients were randomly assigned to standard triple therapy (group A, n = 129) or triple therapy plus ecabet sodium (group B, n = 128). Successful eradication was defined as a negative 13C-urea breath test 6-8 wk after completion of treatment. RESULTS: After completion of therapy, 194/257 patients showed negative 13C-urea breath test results. According to intention-to-treat analysis, the infection was eradicated in 93/129 (72.1%) patients in group A and 101/128 (78.9%) in group B (P = 0.204). Per-protocol analysis showed successful eradication in 93/118 (78.8%) patients from group A and 101/114 (88.6%) from group B (P = 0.044). There were no significant differences in the side effects experienced by the patients in the two treatment groups. CONCLUSION: Our results suggest that the addition of ecabet sodium improves the efficacy of the standard triple therapy for H pylori.
AIM： To investigate whether adding ecabet sodium to the standard triple therapy for H pylori infection improve eradication rate. METHODS： Two hundred and fifty-seven H pylori-infected patients were randomly assigned to standard triple therapy （group A, n = 129） or triple therapy plus ecabet sodium （group B, n = 128）. Successful eradication was defined as a negative 13C-urea breath test 6-8 wk after completion of treatment. RESULTS： After completion of therapy, 194/257 patients showed negative 13C-urea breath test results. According to intention-to-treat analysis, the infection was eradicated in 93/129 （72.1%） patients in group A and 101/128 （78.9%） in group B （P = 0.204）. Per-protocol analysis showed successful eradication in 93/118 （78.8%） patients from group A and 101/114 （88.6%） from group B （P = 0.044）. There were no significant differences in the side effects experienced by the patients in the two treatment groups. CONCLUSION： Our results suggest that the addition of ecabet sodium improves the efficacy of the standard triple therapy for H pylori.
基金
An unrestricted grant by JEIL Pharm.Co.,Ltd.,Korea
